Berbice Capital Management’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-200
Closed -$8.05K 184
2024
Q4
$8.05K Buy
+200
New +$8.05K 0.01% 124